Precision BioSciences, Inc (DTIL) Stock Price

5.42 ▼ -0.60 (-9.97%)
Open: 5.95 Vol: 255.55K Day's range: 5.41 - 5.95 Mar 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DTIL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 5.46▼ 5.47▼ 5.53▼ 6.17▼ 5.65▼
MA10 5.46▼ 5.56▼ 5.69▼ 6.46▼ 4.79▲
MA20 5.48▼ 5.72▼ 6.03▼ 5.78▼ 4.67▲
MA50 5.55▼ 6.17▼ 6.31▼ 4.70▲ 4.99▲
MA100 5.70▼ 6.34▼ 6.19▼ 4.80▲ 6.43▼
MA200 6.05▼ 6.11▼ 5.22▲ 5.01▲ 16.07▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.009▼ -0.059▼ -0.091▼ 0.222▲
RSI 37.245▼ 27.284▼ 26.812▼ 47.905▼ 53.774▲
STOCH 36.045     4.952▼ 6.583▼ 37.612     68.281    
WILL %R -82.353▼ -97.842▼ -98.396▼ -78.058▼ -53.448    
CCI -116.323▼ -106.449▼ -113.184▼ -91.296     86.922    
Latest Filters Detected On DTIL
RSI $DTIL RSI(14) Crossed Below 50 Set Alert
▼ BREAK $DTIL Price Breaks 10 Days Low Set Alert
CDL $DTIL Marubozu Candlestick Pattern Detected Set Alert
Precision BioSciences, Inc News
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Wednesday, March 11, 2026 12:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026
Monday, March 09, 2026 01:15 PM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026
Monday, March 09, 2026 06:16 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
DTIL historical stock data
date open high low close volume
30/03/26 5.95 5.95 5.41 5.42 255,554
27/03/26 6.51 6.51 5.78 6.02 534,176
26/03/26 6.40 6.83 6.40 6.54 237,804
25/03/26 6.45 6.8081 6.32 6.47 210,811
24/03/26 6.48 6.54 6.23 6.40 291,642
23/03/26 6.55 6.5852 6.20 6.52 222,770
20/03/26 6.64 6.8573 6.3726 6.52 548,740
19/03/26 6.95 6.95 6.50 6.72 507,879
18/03/26 6.88 7.59 6.56 7.03 1,100,471
17/03/26 6.35 6.96 6.20 6.93 527,933
Quote Details
52wk Low:3.53
52wk High:8.82
Vol:255.55K
Avg Vol(3m):5.4M
1Y Chng:-1.81%
1M Chng:+35.84%
Add to Watch List
More Information
Index US Composite
Market Cap. 148.85M